These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 144921)

  • 1. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
    Schreiber V; Pribyl T; Jahodová J
    Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
    Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
    Pribyl T; Jahodová J; Schreiber V
    Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
    Schreiber V; Pribyl T; Svobodová V; Jahodová J
    Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic control of adenohypophyseal growth.
    Schreiber V
    Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thyroxine binding to adenohypophysial proteins in vitro by 2,4-dinitrophenol administered in vivo.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1975; 24(2):147-56. PubMed ID: 124882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the weight of adenohypophysis, thyroxine-binding adenohypophyseal proteins in vitro and level of ceruloplasmin in the rat serum: effect of hormones and of various neurotrophic drugs].
    Schreiber V
    Cesk Fysiol; 1976; 25(1):31-4. PubMed ID: 815007
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
    Schreiber V; Pribyl T; Jahodová J
    Endocrinol Exp; 1979 Sep; 13(3):131-8. PubMed ID: 315864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic control of adenohypophysial weight and serum ceruloplasmin level in rats.
    Schreiber V; Pribyl T
    Neuroendocrinology; 1976; 21(1):58-67. PubMed ID: 1004686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
    Schreiber V; Pribyl T; Jahodová J
    Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of furosemide, potassium canrenoate and D-L-propranolol on blood pressure in spontaneously hypertensive rat].
    Altman J; Gordan P; Grünfeld JP
    Pathol Biol (Paris); 1976 May; 24(5):337-41. PubMed ID: 781602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium prorenoate: a new steroidal aldosterone antagonist.
    Hofmann LM; Chinn LJ; Pedrera HA; Krupnick MI; Suleymanov OD
    J Pharmacol Exp Ther; 1975 Aug; 194(2):450-6. PubMed ID: 1151770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oestrogen and ascorbic acid on the serum ceruloplasmin level in rats.
    Pribyl T; Schreiber V
    Physiol Bohemoslov; 1977 Aug; 26(4):325-30. PubMed ID: 144282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.